Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Clinical trial NCT00601978 · WITHDRAWN

Trial details

NCT number: NCT00601978
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2008-08-01
Primary completion: 2009-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.